GenoMed®-Diagnósticos de Medicina Molecular SA

What GenoMed®-Diagnósticos de Medicina Molecular SA does

GenoMed®-Diagnósticos de Medicina Molecular SA is a Portuguese company operating in the molecular diagnostics sector, as indicated by its legal name. Its registered domain (genomed.pt) and Portuguese sociedade anónima (S.A.) corporate structure place the entity in Portugal, though the website presents only a loading or verification screen with no substantive content captured.

The company's name — translating to "Molecular Medicine Diagnostics" — signals a clinical or laboratory focus on molecular-level diagnostic services, a specialty within the broader clinical diagnostics industry. No further details about specific test offerings, platform technology, laboratory infrastructure, or technical methodology are available in the input data. The trademarked GenoMed® brand suggests some degree of brand investment, but the depth of its diagnostic portfolio cannot be verified from current sources.

The business model, pricing structure, customer segments, go-to-market approach, and revenue mechanics are not disclosed. No management team, headcount, funding history, partnerships, or accreditations are documented. The lack of accessible public material indicates either a very early-stage company, a small-scale operation with minimal digital footprint, or an entity with limited outward-facing communications. Further due diligence would be required to assess operational scale, competitive positioning, and financial profile.

Name

GenoMed®-Diagnósticos de Medicina Molecular SA

Legal name

GenoMed®-Diagnósticos de Medicina Molecular SA

Website

https://genomed.pt

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

GenoMed®-Diagnósticos de Medicina Molecular SA is a Portuguese molecular diagnostics company. Its name indicates a focus on molecular medicine diagnostic services, though no specific products, customers, or operational details are disclosed in available data.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Molecular diagnostics
• Genetic testing services
• Clinical laboratory diagnostics
• DNA diagnostic analysis
• Medical molecular testing

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

GenoMed®-Diagnósticos de Medicina Molecular SA appears to be a Portuguese molecular medicine diagnostics company that provides genetic and molecular diagnostic testing services. The company's name indicates specialization in molecular-level disease diagnosis and detection, though specific test offerings could not be confirmed from the available source data because the website was displaying a verification/loading screen.

Product overview

Unable to determine product and service offerings from available source data. The source page displays a loading/verification screen with no accessible content.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• 23andMe: Consumer-facing genetic testing company that has expanded into health-related molecular testing and research collaborations. Comparable as a recognizable brand in genetic testing, though operating in a different channel (DTC vs. clinical referral).

Direct peers

• Centogene: Specialized molecular diagnostics company focused on rare disease and genetic testing across European and global markets. Comparable as a niche molecular diagnostics specialist competing in similar test categories.
• Medicover Genetics: Genetics and molecular diagnostics provider operating across multiple European countries, including offerings in clinical genetic testing. Comparable as a multi-country molecular diagnostics specialist with overlapping test menus.
• Blueprint Genetics: Clinical genetics and molecular diagnostics laboratory focused on inherited disease and rare disorder testing. Comparable as a specialized molecular/genetic diagnostics lab serving clinician referrals.
• CGC Genetics: Portuguese molecular genetics and genomics laboratory offering a broad menu of genetic and molecular diagnostic tests to clinicians and hospitals. Highly comparable as a domestic peer competing in the same niche and geography as GenoMed.

Broad incumbents

• Eurofins Genomics: Global genomics services provider within the Eurofins network, offering molecular testing, sequencing, and genetic diagnostics. Comparable as a scaled incumbent in molecular/genetic testing that competes for European reference lab work.
• Synlab: One of Europe's largest medical diagnostics service networks, operating clinical labs across many countries including Portugal. Comparable as a broad incumbent offering molecular diagnostics alongside a much wider routine test menu.
• Myriad Genetics: Established molecular diagnostics company with a long-standing focus on genetic testing for hereditary conditions and oncology. Comparable as a scaled, branded molecular diagnostics incumbent in adjacent genetic test categories.
• Unilabs: Major European diagnostics provider with extensive clinical laboratory operations including molecular and genetic testing. Relevant as a large incumbent whose reference lab services compete for the same Portuguese hospital and clinician demand.

Regional players

• IPATIMUP Diagnósticos: Portuguese molecular pathology diagnostics provider affiliated with a leading Portuguese cancer research institute. Comparable as a domestic peer offering specialized molecular diagnostics to Portuguese clinicians and hospitals.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/genomed---diagn%C3%B3sticos-de-medicina-molecular-sa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenoMed®-Diagnósticos de Medicina Molecular SA